41 results on '"Bruynzeel, A. M.E."'
Search Results
2. Artificial intelligence-assisted quantitative CT analysis of airway changes following SABR for central lung tumors
3. Impact of Short-Course Palliative Radiation Therapy on Pancreatic Cancer-Related Pain: Prospective Phase 2 Nonrandomized PAINPANC Trial
4. Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide
5. Every-Other-Day Versus Once-a-Week Urethra-Sparing Prostate Stereotactic Body Radiation Therapy: 5-Year Results of a Randomized Phase 2 Trial
6. Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk
7. Magnetic Resonance-guided Stereotactic Radiotherapy for Localized Prostate Cancer: Final Results on Patient-reported Outcomes of a Prospective Phase 2 Study
8. Impact of Short-Course Palliative Radiation Therapy on Pancreatic Cancer-Related Pain: Prospective Phase 2 Nonrandomized PAINPANC Trial
9. A randomized controlled trial on the efficacy of life review therapy targeting incurably ill cancer patients: do their informal caregivers benefit?
10. Clinical Outcomes of Stereotactic MR-Guided Adaptive Radiation Therapy for High-Risk Lung Tumors
11. A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results
12. End-to-end empirical validation of dose accumulation in MRI-guided adaptive radiotherapy for prostate cancer using an anthropomorphic deformable pelvis phantom
13. The role of biological dose-escalation for pancreatic cancer
14. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors
15. Identification of patients with locally advanced pancreatic cancer benefitting from plan adaptation in MR-guided radiation therapy
16. Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer
17. MR-guided Gated Stereotactic Radiation Therapy Delivery for Lung, Adrenal, and Pancreatic Tumors: A Geometric Analysis
18. Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases
19. 2873: Daily intra-fraction corrections in MRI-guided SABR
20. 2536: Long term outcomes of stereotactic MR-guided adaptive radiotherapy for prostate cancer
21. 1989: Daily Organs-At-Risk Variations and Their Impact on Dose Target Coverage in Pancreatic Tumors
22. 934: A comparative analysis of expiration gating and free breathing in pancreatic cancer radiotherapy
23. Impact of Short-Course Palliative Radiation Therapy on Pancreatic Cancer-Related Pain: Prospective Phase 2 Nonrandomized PAINPANC Trial
24. Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms
25. Unresectable Intermediate-Size (3–5 cm) Colorectal Liver Metastases:Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial
26. Isotoxic radiosurgery planning for brain metastases
27. 108: Early Clinical Effectiveness, Toxicity, and Quality of Life Outcomes of Magnetic Resonance Imaging-Guided Stereotactic Ablative Radiotherapy: A Systematic Review
28. Magnetic resonance imaging-guided radiotherapy for intermediate- and high-risk prostate cancer: Trade-off between planning target volume margin and online plan adaption
29. Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR):a nationwide multicenter randomized controlled trial according to a TwiCs design
30. A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE)
31. Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design
32. Treatment patterns for adrenal metastases using surgery and SABR during a 10-year period
33. Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases
34. Impact of daily plan adaptation on organ-at-risk normal tissue complication probability for adrenal lesions undergoing stereotactic ablative radiation therapy
35. 3434: MR-Linac: A new workflow.
36. Dose accumulation for personalized stereotactic MR-guided adaptive radiation therapy in prostate cancer
37. Changes in gastric anatomy after delivery of breath-hold MR-guided SABR for adrenal metastases
38. A randomized controlled trial on the efficacy of life review therapy targeting incurably ill cancer patients: do their informal caregivers benefit?
39. Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results
40. Stereotactic MR-guided adaptive radiation therapy for peripheral lung tumors
41. Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.